Genea

Sydney, Australia Founded: 1986 • Age: 40 yrs Acquired By Liverpool Partners
Technologies for assisted reproductive treatment are developed.
Annual revenue - Latest available
Total funding $30.0M 1 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Genea

Genea is a company based in Sydney (Australia) founded in 1986 by Robert Jansen was acquired by Liverpool Partners in August 2022. Genea has raised $30 million across 1 funding round from investors including Acorn Capital, Mason Group Holdings and LVP.

  • Headquarter Sydney, Australia
  • Founders Robert Jansen
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Maine Potato Growers, Inc
Operational Areas
Not available
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $30 M (USD)

    in 1 rounds

  • Latest Funding Round
    $30 M (USD), Unspecified

    Aug 23, 2015

  • Investors
  • Employee Count
    Not available
  • Acquired by
    Liverpool Partners

    & 1 more

    (Aug 02, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Genea

Headcount 200-500
Employee Profiles 3
Board Members and Advisors 1
Employee Profiles
People
Steven McArthur
Scientific Director
People
Maryam Shamshoon
Scientific Officer

Unlock access to complete

Board Members and Advisors
people
Robert Woolcott
Chairman

Unlock access to complete

Funding Insights of Genea

Genea has successfully raised a total of $30M through 1 strategic funding round. The most recent funding activity was a Unspecified round of $30 million completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Genea

Genea has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Acorn Capital, Mason Group Holdings and LVP.

All
Institutional
Investor Description Founded Year Domain Location
Diversified investment management services are offered by Acorn Capital.
Locked Locked Locked
Delivers comprehensive healthcare services tailored for multiple industries.
Locked Locked Locked
Sustainability-led investments are managed by LVP across Australasia.
Locked Locked Locked
Premium access

Investor details for Genea

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Genea

Investments
Premium access

Investment portfolio details for Genea

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Genea

Premium access

Detailed financials for Genea

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Genea Comparisons

Genea Primary company
Description
Technologies for assisted reproductive treatment are develop...
Location
Sydney, Australia
Founded Year
1986
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Genea

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Genea

Premium access

Detailed competitors of Genea

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Genea

Premium access

Complete news archive for Genea

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Genea

Genea was founded in 1986 and raised its 1st funding round 29 years after it was founded.

Genea is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.

Genea is a funded company, having raised a total of $30M across 1 funding round to date.

Genea was founded in 1986 in Sydney, Australia, within the biotechnology sector focused on fertility. Research and development in assisted reproductive treatments are conducted, including advancements in IVF laboratory technology. The group comprises three interconnected entities: Genea Fertility for clinical services, Genea Biomedx for commercializing IVF innovations globally, and Genea Biocells for maintaining a private bank of human embryonic stem cells representing nearly 30 genetic diseases.

Genea has 3 investors. Key investors include Acorn Capital, Mason Group Holdings, and LVP.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available